SurgCentre was the original topic and for which I commented. My comment was that a 'connection' with SurgeCentre, when a partnership deal is needed with Big Pharma first, does not really play out - that is, once the partnership deal is done (NOT with SurgCentre), who cares WHERE the trial is done?
There's over 1,000 patents (by Mesoblast). All of them worthless without FDA approval.
Yes, it was a change of topic.
At this point, CHF is a distraction to Mesoblast.
once approved, page-48
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.025(2.15%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $1.027M | 879.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1212 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 53769 | 8 |
View Market Depth
| Last trade - 10.46am 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |